Last updated: 18 March 2024 at 4:33pm EST

Dr. Stephen K. Brannan Net Worth




The estimated Net Worth of Stephen K. Brannan is at least $16.3 millió dollars as of 8 March 2024. Dr Brannan owns over 7,500 units of Karuna Therapeutics Inc stock worth over $15,701,227 and over the last 5 years he sold KRTX stock worth over $0. In addition, he makes $624,550 as Chief Medical Officer at Karuna Therapeutics Inc.

Dr Brannan KRTX stock SEC Form 4 insiders trading

Dr has made over 32 trades of the Karuna Therapeutics Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 7,500 units of KRTX stock worth $636,600 on 8 March 2024.

The largest trade he's ever made was exercising 25,000 units of Karuna Therapeutics Inc stock on 9 August 2022 worth over $205,500. On average, Dr trades about 7,777 units every 40 days since 2020. As of 8 March 2024 he still owns at least 47,604 units of Karuna Therapeutics Inc stock.

You can see the complete history of Dr Brannan stock trades at the bottom of the page.





Dr. Stephen K. Brannan biography

Dr. Stephen K. Brannan is the Chief Medical Officer at Karuna Therapeutics Inc.

What is the salary of Dr Brannan?

As the Chief Medical Officer of Karuna Therapeutics Inc, the total compensation of Dr Brannan at Karuna Therapeutics Inc is $624,550. There are 6 executives at Karuna Therapeutics Inc getting paid more, with Steven Paul having the highest compensation of $10,050,700.



How old is Dr Brannan?

Dr Brannan is 65, he's been the Chief Medical Officer of Karuna Therapeutics Inc since . There are 4 older and 10 younger executives at Karuna Therapeutics Inc. The oldest executive at Karuna Therapeutics Inc is Dr. Steven M. Paul M.D., 70, who is the CEO, Pres & Chairman.

What's Dr Brannan's mailing address?

Stephen's mailing address filed with the SEC is C/O KARUNA THERAPEUTICS, INC., 99 HIGH STREET, 26TH FLOOR, BOSTON, MA, 02110.

Insiders trading at Karuna Therapeutics Inc

Over the last 5 years, insiders at Karuna Therapeutics Inc have traded over $496,938,545 worth of Karuna Therapeutics Inc stock and bought 1,501,936 units worth $53,814,390 . The most active insiders traders include Health Llc Pure Tech, James Healy és Robert Nelsen. On average, Karuna Therapeutics Inc executives and independent directors trade stock every 12 days with the average trade being worth of $18,341,187. The most recent stock trade was executed by Stephen K. Brannan on 8 March 2024, trading 7,500 units of KRTX stock currently worth $636,600.



What does Karuna Therapeutics Inc do?

we are an innovative clinical-stage biopharmaceutical company primarily focused on developing novel therapies to address disabling neuropsychiatric conditions characterized by significant unmet medical need. our pipeline is built on the broad therapeutic potential of our lead product candidate, karxt, an oral modulator of muscarinic receptors that are located both in the central nervous system, or cns, and various peripheral tissues. karxt is our proprietary product candidate that combines xanomeline, a novel muscarinic agonist, with trospium, an approved muscarinic antagonist, to preferentially stimulate muscarinic receptors in the cns. we have assembled a team with extensive expertise in the research, development and commercialization of numerous cns agents, as well as deep familiarity with the biology of neuropsychiatric disorders, such as schizophrenia and ad, including the role of muscarinic receptors in their potential treatment. we will leverage this expertise to develop a pip



What does Karuna Therapeutics Inc's logo look like?

Karuna Therapeutics Inc logo

Complete history of Dr Brannan stock trades at Karuna Therapeutics Inc

Dátum
#
Cég
Az érdekelt
Trans.
Tranzakció
Részvények száma Ár per részvény Teljes ár Részvények szíma után Forrás
8 Mar 2024 Stephen K. Brannan
Chief Medical Officer
Opció Gyakorlat 7,500 $84.88 $636,600
8 Mar 2024
47,604
8 Feb 2024 Stephen K. Brannan
Chief Medical Officer
Opció Gyakorlat 7,500 $76.46 $573,450
8 Feb 2024
46,150
8 Jan 2024 Stephen K. Brannan
Chief Medical Officer
Opció Gyakorlat 17,500 $102.71 $1,797,425
8 Jan 2024
53,650
8 Dec 2023 Stephen K. Brannan
Chief Medical Officer
Opció Gyakorlat 12,500 $106.40 $1,330,000
8 Dec 2023
46,150
8 Nov 2023 Stephen K. Brannan
Chief Medical Officer
Opció Gyakorlat 7,500 $89.58 $671,850
8 Nov 2023
38,650
9 Oct 2023 Stephen K. Brannan
Chief Medical Officer
Opció Gyakorlat 7,500 $89.58 $671,850
9 Oct 2023
36,150
8 Sep 2023 Stephen K. Brannan
Chief Medical Officer
Opció Gyakorlat 7,500 $89.58 $671,850
8 Sep 2023
33,650
8 Aug 2023 Stephen K. Brannan
Chief Medical Officer
Opció Gyakorlat 7,500 $89.58 $671,850
8 Aug 2023
31,150
10 Apr 2023 Stephen K. Brannan
Chief Medical Officer
Opció Gyakorlat 5,000 $9.20 $46,000
10 Apr 2023
28,650
9 Mar 2023 Stephen K. Brannan
Chief Medical Officer
Opció Gyakorlat 5,000 $5.45 $27,250
9 Mar 2023
28,650
9 Feb 2023 Stephen K. Brannan
Chief Medical Officer
Opció Gyakorlat 5,000 $5.45 $27,250
9 Feb 2023
20,000
9 Jan 2023 Stephen K. Brannan
Chief Medical Officer
Opció Gyakorlat 5,000 $6.71 $33,550
9 Jan 2023
18,473
9 Dec 2022 Stephen K. Brannan
Chief Medical Officer
Opció Gyakorlat 5,000 $7.80 $39,000
9 Dec 2022
16,363
9 Nov 2022 Stephen K. Brannan
Chief Medical Officer
Opció Gyakorlat 5,000 $9.20 $46,000
9 Nov 2022
20,000
10 Oct 2022 Stephen K. Brannan
Chief Medical Officer
Opció Gyakorlat 5,000 $9.20 $46,000
10 Oct 2022
20,000
9 Sep 2022 Stephen K. Brannan
Chief Medical Officer
Opció Gyakorlat 5,000 $7.27 $36,350
9 Sep 2022
20,000
9 Aug 2022 Stephen K. Brannan
Chief Medical Officer
Opció Gyakorlat 25,000 $8.22 $205,500
9 Aug 2022
27,264
11 Jul 2022 Stephen K. Brannan
Chief Medical Officer
Opció Gyakorlat 15,000 $9.20 $138,000
11 Jul 2022
30,000
9 Jun 2022 Stephen K. Brannan
Chief Medical Officer
Opció Gyakorlat 5,000 $9.20 $46,000
9 Jun 2022
20,000
9 May 2022 Stephen K. Brannan
Chief Medical Officer
Opció Gyakorlat 5,000 $9.20 $46,000
9 May 2022
20,000
1 Apr 2022 Stephen K. Brannan
Chief Medical Officer
Opció Gyakorlat 10,228 $6.83 $69,857
1 Apr 2022
22,728
1 Mar 2022 Stephen K. Brannan
Chief Medical Officer
Opció Gyakorlat 10,228 $8.28 $84,688
1 Mar 2022
20,228
1 Feb 2022 Stephen K. Brannan
Chief Medical Officer
Opció Gyakorlat 10,228 $6.83 $69,857
1 Feb 2022
17,728
30 Dec 2021 Stephen K. Brannan
Chief Medical Officer
Opció Gyakorlat 10,228 $8.28 $84,688
30 Dec 2021
30,228
1 Dec 2021 Stephen K. Brannan
Chief Medical Officer
Opció Gyakorlat 10,228 $6.83 $69,857
1 Dec 2021
27,728
1 Nov 2021 Stephen K. Brannan
Chief Medical Officer
Opció Gyakorlat 10,228 $5.47 $55,947
1 Nov 2021
25,125
1 Jul 2020 Stephen K. Brannan
Chief Medical Officer
Opció Gyakorlat 10,228 $8.28 $84,688
1 Jul 2020
22,728
1 Jun 2020 Stephen K. Brannan
Chief Medical Officer
Opció Gyakorlat 10,228 $6.83 $69,857
1 Jun 2020
20,228
1 May 2020 Stephen K. Brannan
Chief Medical Officer
Opció Gyakorlat 10,228 $5.45 $55,743
1 May 2020
17,728
1 Apr 2020 Stephen K. Brannan
Chief Medical Officer
Opció Gyakorlat 10,228 $8.28 $84,688
1 Apr 2020
15,228
2 Mar 2020 Stephen K. Brannan
Chief Medical Officer
Opció Gyakorlat 10,228 $6.83 $69,857
2 Mar 2020
12,728
19 Feb 2020 Stephen K. Brannan
Chief Medical Officer
Opció Gyakorlat 10,228 $5.45 $55,743
19 Feb 2020
10,228


Karuna Therapeutics Inc executives and stock owners

Karuna Therapeutics Inc executives and other stock owners filed with the SEC include: